Himmelfarb Health Sciences Library, The George Washington University

Health Sciences Research Commons
Medicine Faculty Publications

Medicine

2016

A Point Mutation in DNA Polymerase β (POLB)
Gene Is Associated with Increased Progesterone
Receptor (PR) Expression and Intraperitoneal
Metastasis in Gastric Cancer
Xiaohui Tan
Xiaoling Wu
Shuyang Ren
Hongyi Wang
Weaam Alshenawy
See next page for additional authors

Follow this and additional works at: http://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs
Part of the Cancer Biology Commons, Genetics and Genomics Commons, and the Medicine and
Health Sciences Commons
APA Citation
Tan, X., Wu, X., Ren, S., Wang, H., Alshenawy, W., Li, W., Cui, J., Luo, G., Siegel, R. S., Fu, S. W., & Lu, Y. (2016). A Point Mutation in
DNA Polymerase β (POLB) Gene Is Associated with Increased Progesterone Receptor (PR) Expression and Intraperitoneal
Metastasis in Gastric Cancer. Journal of Cancer, 7 (11). http://dx.doi.org/10.7150/jca.14844

This Journal Article is brought to you for free and open access by the Medicine at Health Sciences Research Commons. It has been accepted for
inclusion in Medicine Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please
contact hsrc@gwu.edu.

Authors

Xiaohui Tan, Xiaoling Wu, Shuyang Ren, Hongyi Wang, Weaam Alshenawy, Wenmei Li, Jiantao Cui,
Guangbin Luo, Robert S. Siegel, Sidney W. Fu, and Youyong Lu

This journal article is available at Health Sciences Research Commons: http://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/
792

Journal of Cancer 2016, Vol. 7

1472

Ivyspring

Journal of Cancer

International Publisher

2016; 7(11): 1472-1480. doi: 10.7150/jca.14844

Research Paper

A Point Mutation in DNA Polymerase β (POLB) Gene Is
Associated with Increased Progesterone Receptor (PR)
Expression and Intraperitoneal Metastasis in Gastric
Cancer
Xiaohui Tan1, 6*, Xiaoling Wu2, 6*, Shuyang Ren1, Hongyi Wang3, Zhongwu Li4, Weaam Alshenawy6,
Wenmei Li1, Jiantao Cui1, Guangbin Luo5, Robert S. Siegel6, Sidney W. Fu6 and Youyong Lu1
1.
2.
3.
4.
5.
6.

Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of
Oncology, Beijing Cancer Hospital & Institute, 52# Fu-Cheng-Lu, Hai-Dian District, Beijing, 100142, China;
Department of Gastroenterology, The Chengdu Military General Hospital, Chengdu, China;
Department of Sugary, Peking University School of Oncology, Beijing Cancer Hospital & Institute, 52# Fu-Cheng-Lu, Hai-Dian District, Beijing, 100142,
China;
Department of Pathology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, 52# Fu-Cheng-Lu, Hai-Dian District, Beijing, 100142,
China;
Department of Genetics, Case Western Reserve University, Cleveland, OH 44106, USA;
Department of Medicine, The George Washington University School of Medicine and Health Sciences, 2300 Eye Street, N.W. Ross Hall 402C, Washington,
DC 20037, USA.

*These

authors contributed equally to this work.

 Corresponding authors: Sidney W. Fu, sfu@gwu.edu or Youyong Lu , youyonglu@sina.com.
© Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See
http://ivyspring.com/terms for terms and conditions.

Received: 2015.12.29; Accepted: 2016.03.15; Published: 2016.07.05

Abstract
Increased expression of progesterone receptor (PR) has been reported in gastric cancer (GC).
We have previously identified a functional T889C point mutation in DNA polymerase beta
(POLB), a DNA repair gene in GC. To provide a detailed analysis of molecular changes associated
with the mutation, human cDNA microarrays focusing on 18 signal transduction pathways were
used to analyze differential gene expression profiles between GC tissues with T889C mutant in
POLB gene and those with wild type. Among the differentially expressed genes, notably, PR was
one of the significantly up-regulated genes in T889C mutant POLB tissues, which were
subsequently confirmed in POLB gene transfected AGS cell line. Interestingly, patients with T889C
mutation and PR positivity were associated with higher incidence of intraperitoneal metastasis
(IM). In vitro studies indicate that PR expression was upregulated in AGS cell line when transfected
with T889C mutant expression vector. Cotransfection of T889C mutant allele and PR gene
induced cell migration in the cell line. These data demonstrated that T889C mutation-associated
PR overexpression results in increased IM. Therefore, T889C mutation-associated PR
overexpression may serve as a biomarker for an adverse prognosis for human GC.
Key words: Gastric cancer, DNA polymerase beta, progesterone receptor, metastasis.

Introduction
Gastric cancer (GC) is the fourth most commonly
diagnosed malignancy and the second leading cause
of cancer-related mortality worldwide [1]. Influences
of sex-hormones on gastric cancer development have
been studied [2]. Progesterone is a critical regulator of

normal female reproductive function, with diverse
tissue-specific effects in humans. Progestogen has
been classified by the International Agency for
Research on Cancer (IARC) as possibly carcinogenic
to humans and plays a role in cancer development
http://www.jcancer.org
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and progression [3]. The effects of progesterone
mediated by its nuclear receptor, progesterone
receptors (PR), have been reported in adenocarcinoma
of the stomach [4]. Further, primarily altering PR
expression levels rather than impacting PR
transcriptional activity has been reported to be
involved in human cancer progression [5]. However,
the roles of PR expression in GC are poorly defined.
Defective DNA repair can result in genomic
instability and consequently induce oncogenic
alterations. Base excision repair (BER) is a key
pathway for maintaining genomic stability. A key
enzyme in the BER pathway is DNA polymerase beta
(POLB)
[6-9].
POLB
gene
mutation
and
overexpression have been reported in various cancers
including GC [10-13]. However, the detailed
mechanism remains unclear.
In our previous studies, we identified a unique
T889C missense mutation in POLB gene in human
primary GCs [14]. Here, we investigate changes in
gene expression associated with the T889C mutation
in POLB gene using cDNA microarray technology.
Interestingly, among the differentially expressed
genes, notably, PR was one of the significantly
up-regulated genes in T889C mutant POLB tissues.
Patients with T889C mutation and PR positivity were
associated with higher incidence of intraperitoneal
metastasis (IM). Further functional relationship
between PR expression and T889C mutation in GC
cell line was investigated.

Materials and Methods
Cell lines and tissue samples
Human GC cell line AGS was obtained from the
American Type Culture Collection (ATCC) and
cultured in Dulbecco's modified Eagle's medium
(DMEM) (Gibco) containing 10% fetal bovine serum
(Gibco) and 10 μg/ml vancomycin. Primary GC
specimens and their matched normal adjacent tissues
were collected at the time of surgery. None of the
patients had received any chemotherapy or
radiotherapy before surgical resection. Tissue samples
were snap-frozen in liquid nitrogen until further use.
Clinical and histological features were evaluated
(Table 1). Tumor tissues were histologically classified
according to the Lauren’s classification. The study
was conducted according to the Helsinki Declaration,
approved by the Institutional Ethical Standards
Committee of Peking University and informed
consents were obtained from all patients in this study.

RNA extraction
Total RNA was isolated from the cells using the
Trizol reagent (LifeTachnologies) following the
manufacturer’s instructions. Total RNA from excised
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tissue samples was isolated using the RNeasy Mini
Kit
(Qiagen)
following
the
manufacturer's
recommendations. The quality and quantity of the
extracted total RNA was assessed by the
spectrophotometric ultraviolet (UV) instrument.
Table 1. Clinical and pathologic parameters of the 70 patient
samples used in mutation analysis.
Tissues parameters
Tumor
Gender
Male
Female
Age (years)
Male
Female
Pathology
Intestinal
Diffuse
Mixed
Adenosquamous
Tumor location
GOJ a
Fundus
Greater curve-body
Lesser curve-body
Body nonspecified
Antrum
Differentiation
Well
Moderate to poor
Poor
Depth of invasion
Mucosa
Submucosa
Muscularis propria
Serosa/full thickness
Intraperitoneal metastasis
+
a

Number
70
36
34
31-71
29-73
48
15
3
4
31
6
10
8
7
8
14
33
23
6
7
10
47
26
44

Gastro-oesophageal junction.

cDNA expression array analysis
Microarray gene expression analysis was
conducted
using
the
nonradioactive
signal
transduction pathway finder GEArray Q series kit
(GEArray Q Series HS-008-12/ HS-008N-12;
SuperArray Inc., Bethesda, MD, USA), in accordance
with the manufacturer’s instructions. This array
membrane is comprised of 96 signal transduction
pathway genes, a plasmid pUC18 negative control,
and
four
housekeeping
genes,
including
glyceraldehyde-3-phosphate
dehydrogenase
(GAPDH), cyclophilin A, ribosomal protein L13a, and
β-actin, each of which was printed with the Tetra
Spots format. cDNA probes were synthesized from 5
μg of total RNA by gene-specific primers (supplied
with the SuperArray kit) with biotin-16-dUTP. After 2
hours of pre-hybridization at 60°C, with GEAhyb
Hybridization Solution (SuperArray) containing 100
μg of DNA/ml of denatured salmon sperm DNA
(Invitrogen), the array membranes were hybridized
http://www.jcancer.org
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overnight with denatured cDNA probes at 60°C. The
membranes were then washed twice with 2x SSC, 1%
SDS, and twice with 0.1x SSC, 0.5% SDS, for 15
minutes each at 60°C and the membrane was blocked
for 40 minutes with GEAblocking Solution Q
(SuperArray), then incubated with alkaline
phosphatase-conjugated streptavidin for 10 minutes
at room temperature. Chemiluminescent detection
was conducted using the CDP-Star chemiluminescent
substrate, and images of the arrays were acquired on
X-ray films. The images were then scanned with a
TouchToss SIS-3800 scanner (Samsung, Seoul, Korea).
The resultant scanned images were converted to raw
data files using the Scanalyse software. GEArray
Analyzer software (SuperArray Inc.) was used for
data analysis. The relative expression levels of the
different genes were estimated via comparisons of
their respective signal intensities with that of the
internal controls. Genes were considered as not being
expressed if their expression level was <20% of the
control gene. The fold change of at least 1.5 fold is
considered significant. The expression data was
confirmed using the real-time PCR.

Semi-quantitative RT-PCR and real time PCR
assays
First-strand cDNA was synthesized using the RT
kit (SuperScript preamplification system; Life
Technologies, Inc.-BRL). PR gene has two isoforms, A
(PRA) and B (PRB) using two distinct promotors and
translation start sites in the first exon. The two
isoforms are indistinguishable by PCR primers we
used for mRNA expression analysis. Primer
sequences are available upon request. Total RNA (5
μg) was reverse-transcribed in the presence of 25
ng/μl of oligo (deoxythymidine) primer (Life
Technologies, Inc.) Subsequently, 5 μl of the resulting
cDNA were used as templates for PCR. The products
were resolved on a 2.5% agarose ethidium bromide
gel. Images were captured with Polaroid film under
ultraviolet light. Products were quantified using the
PhosphorImager
and
ImageQuant
software
(Molecular Dynamics, Inc.). Real-time PCR assays
were carried out on a Bio-Rad iCycler iQ system
(Bio-Rad, Hercules, CA, USA) using SYBR Green
reagent [13].

Tissue microarray construction,
immunohistochemical staining and evaluation
Tissue microarrays were constructed as
described previously [15]. Briefly, the GC tissues and
matched normal gastric mucosa were ethanol fixed,
paraffin embedded for creating tissue microarrays.
H&E-stained sections were used for histological
verification. An affinity purified goat polyclonal

1474
antibody POLB (sc-5927, Santa Cruz) was used for
immunohistochemical staining. All the slides were
stained by the avidin-biotin-peroxidase (ABC)
protocol. The labeling index (LI) of POLB gene was
determined by counting tumor and normal cells
stained with the antibody. For evaluation, the total
fields were counted microscopically under high
power (×200). The results of POLB expression were
graded as: negative (-), <5% of cell stained; positive
(+), >5% of cells stained.

Construction of eukaryotic expression vector
and transfection
The entire coding region of cDNA containing
wild type POLB was amplified by RT-PCR, and the
T889C mutant POLB was obtained by site-directed
mutagenesis before they were cloned into pcDNA3.1
vector. The pCMV6-XL4/PR containing PRA and PRB
cDNA sequence was purchased from Origene
Company. AGS cells were transfected with either
POLB wild type or T889C mutant plasmids, along
with PR expression plasmid. 5 X 105 cells were plated
in 10 cm2 culture dishes, and 2.5 μg of plasmid
DNA/dish was transfected using the calcium
phosphate precipitation method.

Immunofluorescence assays
Cells were seeded at 2 × 104 cells per well on
glass coverslips in six-well plates and fixed in 2%
paraformaldehyde as described previously [16] .
Confocal images were obtained using a LSM 510
Confocal microscope (Carl Zeiss). The number of
nuclei containing at least one localized area of
immunofluorescence was determined by examination
of
the
confocal
images.
Antibodies
for
immunofluorescence were as follows: goat polyclonal
antibody POLB (sc-5927, Santa Cruz) at final
concentration (1:600), Rabbit anti-progesterone
receptor Polyclonal antibody (NBP1-61401, Novus
Biologicals, 1:500), Alexa Flour 568 goat anti-mouse
IgG (Invitrogen), 1:500 and Alexa Flour 568 goat
anti-mouse IgG (Invitrogen), 1:500.

Western blot analysis
Protein extraction and Western blot analysis
with chemiluminescent detection were as described
[16]. The following antibodies and dilution factors
were used: affinity purified goat polyclonal antibody
POLB (sc-5927, Santa Cruz, 1:800), Rabbit
anti-progesterone receptor polyclonal antibody
(NBP1-61401, Novus Biologicals, 1:500), rabbit
anti-actin (H-196, Santa Cruz, 1:1000), donkey
anti-goat IgG-HRP (sc-2020, Santa Cruz, 1:2000) and
goat anti-rabbit IgG-HRP (sc-2030, Santa Cruz,
1:2000).
http://www.jcancer.org
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Transwell matrigel invasion assay
Matrigel invasion assays were performed using
the BD BioCoat™ Matrigel™ Invasion Chamber (BD
Biosciences). BD BioCoat Matrigel Invasion Chambers
provide cells with the conditions that allow
assessment of their invasive property in vitro. It
consists of a BD Falcon™ TC Companion Plate with
Falcon Cell Culture Inserts containing an 8 micron
pore size PET membrane with a thin layer of matrigel
basement membrane matrix. Briefly, prior to the start
of each experiment, 500 μl of warm (37°C) serum-free
DMEM medium was added to the upper and lower
chambers and allowed to rehydrate for 2h in a 37°C
cell culture incubator. After 2h rehydration, the
medium was removed from the upper and lower
chambers, 750 μl of DMEM with 10% fetal bovine
serum was added to lower chambers. Then 2.5 x 105
AGS cells transfected with PR, wild-type or mutant
POLB and negative control for 24h were seeded onto
the top chamber cultured in 500 μl serum-free DMEM
with 0.1% BSA in the top chamber. Cells were
incubated in a matrigel chamber in a 37°C humidified
incubator with 5% CO2 for 24 h. The non-invasive
cells were removed from the upper surface of the
membrane by scrubbing with a cotton swab and the
invasive cells present on the bottom of the membrane
were fixed, stained with the Diff-Quick staining
solution and counted (five microscope fields under
the 10X len). Experiments were done in duplicates for
each cell line at least four times. Cell counts were
performed on five nonoverlapping random fields for
each chamber and four chambers were counted for
each experimental point, and the number of invasive
cells was compared to the corresponding control [17].

Statistical analysis
Means ± SD were calculated, and statistical
analysis was performed using one-way ANOVA,
followed by the nonparametric Kruskal-Wallis test; P
< 0.05 was considered statistically significant.

Results
POLB T889C mutation altered gene
expression profile in GC
In order to characterize the signal transduction
pathways that might be modulated by the T889C
mutation in POLB gene, we conducted a series of
microarrays. The GEArray Signal Transduction
Pathway Finder Gene Array membrane contains 96
marker genes, which are associated with 18 different
signal transduction pathways (Mitogenic Pathway,
Wnt Pathway, Hedgehog Pathway, TGF-β Pathway,
Survival Pathway, p53 Pathway, Stress Pathway,
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NF-κB Pathway, NFAT Pathway, CREB Pathway,
Jak-Stat Pathway, Estrogen Pathway, Androgen
Pathway, Calcium and Protein Kinase C Pathway,
Phospholipase C Pathway, Insulin Pathway, LDL
Pathway, and Retinoic Acid Pathway) and four
housekeeping genes, including GAPDH, cyclophilin
A, ribosomal protein L13a, and β-actin. Patient
cohorts included paired GC and their adjacent normal
samples from 10 patients with wild-type and 10
patients with T889C mutant POLB gene. The
expression profiles of GC samples with wild-type and
T889C mutant POLB gene were analyzed by the
Superarray platform. These data were evaluated
using the GEArray Analyzer. Upregulated PR
expression was detected in 8 of 10 tumor samples
with mutant T889C POLB, while only in 3 of 10
wild-type tumor samples compared with matched
normal tissues (P < 0.05). In addition, upregulated
CIAP2
(Homo
sapiens
baculoviral
IAP
repeat-containing 2) and Krox-24/EGR-1 (Early
growth response 1) expression was found in 7 of 10
tumor samples with T889C mutation, while in 3 of 10
for CIAP2 and 4 of 10 for EGR-1 in wild-type tumor
samples, compared with matched normal tissues.
Upregulated c-Fos gene was identified in 6 of 10
tumor samples with T889C mutation while only in 2
of 10 wild-type tumor samples compared with
matched normal tissues (P < 0.05) (Figure 1A, 1B and
Supplementary Table 1). Since upregulated PR
expression was frequently associated with T889C
mutation, we determined to focus on the clinical
significance of this association in GC prognosis.

POLB and PR co-expression was expressed
more frequently in GC tissue with POLB
T889C mutation compared to that without
the mutation
To confirm the cDNA array results, 70 GC
samples (Table 1) including 18 GC tissues with the
mutation and 52 without were subjected to real-time
PCR analysis. POLB overexpression was detected in
16 of 18 (88.9%) GC tissues with T889C mutation, and
31 of 52 (59.6 %) GC tissues without the mutation. PR
overexpression was observed in 13 of 18 (72.2%) GCs
with the mutation whereas in 14 of 52 (26.9 %) GCs
without the mutation.
There was a significant positive correlation
between
T889C
point
mutation
and
PR
overexpression (P < 0.05). Co-expression of POLB and
PR was observed in 13 of 18 (72.2%) GCs with the
mutation (including 11 co-overexpression and 2
co-downexpression) whereas in 9 of 52 (17.3%) GCs
without the mutation (Figure 1C and 1D).

http://www.jcancer.org

Journal of Cancer 2016, Vol. 7

1476

Figure 1. Co-expression of POLB and PR associated with T889C mutation. A. Superarray Q Series HS-008-12/ HS-008N-12. B. A representative cDNA
array results to determine T889C mutation related genes in human GC tissues with and without T889C mutation. Gene expression was compared with matched
normal adjacent tissues. Detectable upregulated genes upon normalization were marked in arrows. C. A representative gel-based RT-PCR for POLB and PR mRNA
expression in tumor and the matched normal tissue from representative GCs. D. Real-time PCR detection of 11 co-overexpression and 2 co-downexpression of
POLB and PR mRNA in GCs with the mutation in tumor (T) vs. matching normal (N).

To examine the expression in protein level, we
constructed tissue microarrays consisting of GC
samples from the 70 patients (Table 1) and 20 normal
adjacent tissues (5 matched adjacent normal tissues
with the T889C mutation and 15 matched adjacent
normal tissues without the mutation). Expression of
POLB and PR status was analyzed by
immunohistochemistry. The positive hybridization
signals of POLB protein were observed in 47 (67.1%)
of 70 GCs, including 16 of 18 (88.9%) GC tissues with
T889C mutation, of which one was from the 5

matched samples, and 31 of 52 (59.6 %) GC tissues
without the mutation, of which four were from the 15
matched samples (Table 2). Positive PR proteins were
detected in 30 of 70 (42.9%) GCs, including 13 of 18
(72.2%) GC tissues with T889C mutation and 17 (32.7
%) of 52 GC tissues without the mutation.
Co-expression of POLB and PR protein was detected
in 10 of 18 (55.6%) GCs with the mutation, including 9
co-positive signals (POLB+/PR+) and one co-negative
signal (POLB-/PR-). Co-expression of two proteins
was detected in 7 of 52 (13.5%) GCs without the
http://www.jcancer.org
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mutation, including 4 POLB+/PR+ and 3 POLB-/PR-,
in addition to 3 of 20 (15%) matched adjacent normal
tissues (Figure 2 and Table 2). The co-expression of
two proteins was significantly different between GCs
with- and without- the T889C mutation (p<0.01). Our
data suggests that T889C mutation significantly
correlated with the co-expression of POLB and PR
genes.

Co-expression of POLB and PR genes is
associated with intraperitoneal metastasis
(IM)
We next investigated whether the co-expression
of POLB and PR correlates with clinicopathological
parameters, such as gender, age, tumor location,
depth of invasion, differentiation and metastasis in
the 70 samples from primary GC patients. Of the 70
samples from GC patients, IM are present in 26
(37.1%) of the patients (Table 1). In 17 patients with
T889C mutation, IM was presents in 7 of 9 (77.8%)
with POLB+/PR+ signals, and in 3 of 8 (37.5%) with
POLB+/ PR- or POLB-/ PR+ signals. In 49 patients
with wild type POLB, IM was present in 2 of 4 (50%)
with POLB+/PR+ signals, 14 of 45 (31.1%) patients
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with non- coexpression signals. There were significant
differences between the patients with coexpression
and non-coexpression of POLB and PR signals in
regard to IM (p = 0.002, Table 3) in patients with
T889C mutation. Thus, co-expression of POLB and PR
was more likely associated with increased
susceptibility of IM in patients with T889C mutation.
Our results suggest that co-expression of POLB and
PR plays a role during metastasis of GC with T889C
mutation.
Table 2. Correlation of POLB and PR expression between GC
samples with mutant T889C and wild type POLB on tissue arrays.
Samples
Tumor
Mutation
Wild type
Total
Normal
Mutation
matched
Wild type
matched
Total

POLB
+－

PR
+－

Co-expression
Co+* Co－* +/－

Total

16(88.9%) 2
31(59.6%) 21
47 23

13 (72.2%) 5
17(26.9%) 35
30 40

9(50%) 1 8
4(7.7%) 3 45
13 4 53

18
52
70

1(25%) 4

1(20%) 4

1(20%) 0 4

5

4(36.3%) 11

1(6.7%) 14

1(6.7%) 1 13

15

5 15

2 18

2 1 17

20

*p < 0.01.

Figure 2. Coexpression of PR and POLB protein in representative GC tissues with T889C mutation. Panels A and B show protein signals stained with
PR and POLB antibodies in same GC sample, so do panels C and D for another GC case. Panels E and F show protein signals stained with PR and POLB antibodies
in the same matched normal sample.

http://www.jcancer.org
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Table 3. Coexpression of POLB and PR associated with increased
IM.
Protein signals POLB+/ PR+
POLB
Mutation
IM
No IM
POLB Wild
type
IM
No IM

Total

9

POLB-/PR- POLB+/PR- and
POLB-/PR+
1
8

7 (77.8%)*
2 (22.2%)*
4

0
1
3

3 (37.5%)
5 (62.5%)
45

10
8
52

2 (50%)
2 (50%)

0
3

14 (31.1%)
31 (68.9%)

16
36

18

*p < 0.01.

Transfected T889C mutation elevates PR
expression in human GC cell lines
Having established the relationship between
T889C mutant POLB and PR gene expression in GC
tissues, we tested whether the T889C mutant POLB
affects PR levels in vitro. We analyzed PR expression
on mRNA level by real time PCR and protein level by
Western blot and Immunofluorescence after
transfecting plasmids containing T889C mutant POLB
or wild type POLB into AGS cells. PR expression was
significantly increased in T889C mutant POLB
transfected cell lines compared to the cells expressing
wild-type POLB (Figure 3A, 3C and 3E). There was no
significant change of POLB expression when
transfected pCMV6-XL4/PRB PR expression plasmid
to AGS cells (Figure 3B, 3D and 3E). These results
indicate that the T889C mutant POLB have somehow
increased PR expression, though the exact mechanism
that is yet to be elucidated.

Co-transfection of T889C mutant POLB and
PR promotes cell invasion in human GC cell
lines
We have observed the relationship between
co-expression of POLB and PR, and increased IM.
Since cell migration is a critical property for cancer
cell metastasis, we further investigated the cell
invasiveness using in vitro invasion assays. Cells
co-transfected with T889C mutant POLB and PR
showed a significant increase in the number of
migrated cells, compared to those co-transfected with
wild type POLB and PR, or T889C mutant POLB, or
wild type POLB or PR alone (Figure 3F). We found
that AGS cell line transfected with mutant POLB
plasmid exhibited significant increase of invasion
ability compared to the wild-type POLB as well as the
empty vector control (p<0.01) (Figure 3G). Moreover,
AGS cell line transfected with mutant POLB plasmid
along with PR expression plasmid showed more
significant invasion compared to the wild-type POLB
plasmid with PR expression plasmid (p<0.01) (Figure

3G). These results indicate that T889C mutation alone,
or with enhanced PR expression promotes invasion
properties of GC cells.

Discussion
Based on our previous studies [14, 18], we
predicted that the T889C mutation in POLB gene
mediates GC progression by affecting the global gene
expression and associated molecular pathways. Thus,
our goal was to identify the differentially expressed
genes and understand the mechanisms of their
differential regulation by comparing wild type and
T889C mutant POLB gene in GC tissue and cell line. In
this study, we performed targeted gene expression
profiling to understand how the T889C mutation in
POLB gene altered molecular pathways associated
with GC. We identified dramatic gene expression
differences at the transcriptional level between wild
type and mutant T889C POLB gene carrying GCs. The
results were further verified by RT-PCR, real-time
PCR and immunofluorescence assays. Interestingly,
we identified a T889C mutation-driven gene signature
that is associated with significant PR overexpression
in human GCs, resulting in increased IM. However,
we did not observe a correlation between
overexpression of PR and POLB with either age or sex
[18]. Additionally, transfection of GC cells expressing
only mutant T889C POLB increased PR expression,
which further implicated that the T889C mutation
upregulated PR expression. Our studies support a
mechanistic link between mutant T889C POLB in PR
specific action and GC cell metastasis.
Existing data suggest that sex hormonal factors
are involved in a variety of cancers including gastric
cancer [19]. Progesterone has been found to increase
the migration of breast cancer cells [20]. The role of
sex hormones in the pathogenesis of cancer is still not
clear. Our data suggest that the increased IM in GC
associated with mutant T889C POLB may be due to
the modulation of PR overexpression, which is related
to tumor metastatic pathways. Further studies may
shed light on the exact mechanisms of these important
findings.

Conclusions
The T889C point mutation in POLB gene is
strongly associated with increased PR expression in
both GC tissue and cell line. The T889C
mutation-associated PR overexpression increased IM
in
GC.
Therefore,
detection
of
T889C
mutation-associated PR overexpression may serve as
a biomarker for an adverse prognosis of human GC.
The exact mechanism of how POLB mutation affects
PR expression is yet to be elucidated.

http://www.jcancer.org
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Figure 3. The T889C mutant POLB increase PR expression in human GC cell line, AGS. Cells were transfected with pcDNA3.1, wild type POLB, T889C
mutant POLB, PR plasmids and co-transfection of these plasmids into AGS cell line. The expression of PR and POLB was analyzed by real time PCR (A and B),
Western blot (C and D) and immunofluorescence (E, red signals are PR, and green signals are POLB). F. The effect on cell invasion by co-transfection of T889C
mutant expression vector and PR expression plasmid in human GC cell line, AGS. The Transwell assay with matrigel was performed for the invasion activity of AGS
cells transfected with pcDNA3.1, WT POLB, T889C mutant POLB, PR plasmids and co-transfection of these plasmids. Cells co-transfected T889C mutant POLB with
PR show a significant increase in the number of migrated cells. Co-transfected wild type POLB and PR show a slightly weak migration, while single transfection of WT
POLB, T889C mutant POLB, and PR presents a decreased migration. G. Invasion ability of the cells is displayed as an absolute cell numbers. Results are displayed as
mean data ± SE. (**P <0.01). Five fields of unit area on each membrane or whole membrane were counted for cell numbers, and the experiments were repeated at
least four times in duplicate.

Supplementary Material
Supplementary table 1.
http://www.jcancer.org/v07p1472s1.xlsx

Abbreviations
GC, Gastric cancer; POLB, DNA polymerase
beta; PR, progesterone receptors; IM, intraperitoneal
metastasis.
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